Abstract
Autologous bone marrow mononuclear cell (BM-MNC) therapy for patients with ST-segment elevation myocardial infarction (STEMI) has produced inconsistent results, possibly due to BM-MNC product heterogeneity. Patient-specific cardiovascular risk factors (CRFs) may contribute to variations in BM-MNC composition. We sought to identify associations between BM-MNC subset frequencies and specific CRFs in STEMI patients. Bone marrow was collected from 191 STEMI patients enrolled in the CCTRN TIME and LateTIME trials. Relationships between BM-MNC subsets and CRFs were determined with multivariate analyses. An assessment of CRFs showed that hyperlipidemia and hypertension were associated with a higher frequency of CD11b+ cells (P = 0.045 and P = 0.016, respectively). In addition, we found that females had lower frequencies of CD11b+ (P = 0.018) and CD45+CD14+ (P = 0.028) cells than males, age was inversely associated with the frequency of CD45+CD31+ cells (P = 0.001), smoking was associated with a decreased frequency of CD45+CD31+ cells (P = 0.013), glucose level was positively associated with the frequency of CD45+CD3+ cells, and creatinine level (an indicator of renal function) was inversely associated with the frequency of CD45+CD3+ cells (P = 0.015). In conclusion, the frequencies of monocytic, lymphocytic, and angiogenic BM-MNCs varied in relation to patients’ CRFs. These phenotypic variations may affect cell therapy outcomes and might be an important consideration when selecting patients for and reviewing results from autologous cell therapy trials.
Similar content being viewed by others
Abbreviations
- BM:
-
Bone marrow
- BM-MNC:
-
Bone marrow mononuclear cell
- CCTRN:
-
Cardiovascular cell therapy research network
- CRF:
-
Cardiovascular risk factor
- IHD:
-
Ischemic heart disease
- LVEF:
-
Left ventricular ejection fraction
- MI:
-
Myocardial infarction
- STEMI:
-
ST-segment elevation myocardial infarction
References
Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222–1232. doi:10.1056/NEJMoa051779
Barth SD, Kaaks R, Johnson T, Katzke V, Gellhaus K, Schulze JJ, Olek S, Kuhn T (2016) The ratio of regulatory (FOXP3+) to total (CD3+) T cells determined by epigenetic cell counting and cardiovascular disease risk: a prospective case-cohort study in non-diabetics. EBioMedicine. doi:10.1016/j.ebiom.2016.07.035
Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114:1852–1866. doi:10.1161/CIRCRESAHA.114.302721
Bjorkbacka H (2016) Can circulating regulatory T cells predict cardiovascular disease? EBioMedicine. doi:10.1016/j.ebiom.2016.08.044
Black MA, Cable NT, Thijssen DH, Green DJ (2009) Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol 297:H1109–H1116. doi:10.1152/ajpheart.00226.2009
Black MA, Green DJ, Cable NT (2008) Exercise prevents age-related decline in nitric-oxide-mediated vasodilator function in cutaneous microvessels. J Physiol 586:3511–3524. doi:10.1113/jphysiol.2008.153742
Caligiuri G, Nicoletti A, Poirier B, Hansson GK (2002) Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 109:745–753. doi:10.1172/JCI7272
Cogle CR, Wise E, Meacham AM, Zierold C, Traverse JH, Henry TD, Perin EC, Willerson JT, Ellis SG, Carlson M, Zhao DX, Bolli R, Cooke JP, Anwaruddin S, Bhatnagar A, da Graca Cabreira-Hansen M, Grant MB, Lai D, Moye L, Ebert RF, Olson RE, Sayre SL, Schulman IH, Bosse RC, Scott EW, Simari RD, Pepine CJ, Taylor DA, Cardiovascular Cell Therapy Research N (2014) Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Circ Res 115:867–874. doi:10.1161/CIRCRESAHA.115.304353
Cutini PH, Campelo AE, Agriello E, Sandoval MJ, Rauschemberger MB, Massheimer VL (2012) The role of sex steroids on cellular events involved in vascular disease. J Steroid Biochem Mol Biol 132:322–330. doi:10.1016/j.jsbmb.2012.08.001
de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ (2014) Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv 7:156–167. doi:10.1161/CIRCINTERVENTIONS.113.001009
Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, Seals DR (2007) Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100:1659–1666. doi:10.1161/01.RES.0000269183.13937.e8
Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, Smith CW (1992) Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90:1335–1345. doi:10.1172/JCI115999
Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, de la Fuente L, Gomez-Bueno M, Cantalapiedra A, Fernandez J, Gutierrez O, Sanchez PL, Hernandez C, Sanz R, Garcia-Sancho J, Sanchez A (2004) Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95:742–748. doi:10.1161/01.RES.0000144798.54040.ed
Ge Y, Cheng S, Larson MG, Ghorbani A, Martin RP, Klein RJ, O’Donnell CJ, Vasan RS, Shaw SY, Wang TJ, Cohen KS (2013) Circulating CD31 + leukocyte frequency is associated with cardiovascular risk factors. Atherosclerosis 229:228–233. doi:10.1016/j.atherosclerosis.2013.04.017
Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346:340–352. doi:10.1056/NEJMra000471
Gyongyosi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, Marban E, Assmus B, Henry TD, Traverse JH, Moye LA, Surder D, Corti R, Huikuri H, Miettinen J, Wohrle J, Obradovic S, Roncalli J, Malliaras K, Pokushalov E, Romanov A, Kastrup J, Bergmann MW, Atsma DE, Diederichsen A, Edes I, Benedek I, Benedek T, Pejkov H, Nyolczas N, Pavo N, Bergler-Klein J, Pavo IJ, Sylven C, Berti S, Navarese EP, Maurer G, Investigators A (2015) Meta-analysis of cell-based cardiac studies (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res 116:1346–1360. doi:10.1161/CIRCRESAHA.116.304346
Harrison DG, Marvar PJ, Titze JM (2012) Vascular inflammatory cells in hypertension. Front Physiol 3:128. doi:10.3389/fphys.2012.00128
Heimbeck I, Hofer TP, Eder C, Wright AK, Frankenberger M, Marei A, Boghdadi G, Scherberich J, Ziegler-Heitbrock L (2010) Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry A 77:823–830. doi:10.1002/cyto.a.20942
Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS (2007) Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 116:1671–1682. doi:10.1161/CIRCULATIONAHA.107.694778
Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B (2012) Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:551–568. doi:10.1161/CIRCULATIONAHA.111.086074
Kandala J, Upadhyay GA, Pokushalov E, Wu S, Drachman DE, Singh JP (2013) Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol 112:217–225. doi:10.1016/j.amjcard.2013.03.021
Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T (2003) Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107:461–468
Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, Sohn YD, Lee MY, Houge MA, Yoon YS (2010) CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res 107:602–614. doi:10.1161/CIRCRESAHA.110.218396
Kim SY, Lee JH, Kim HJ, Park MK, Huh JW, Ro JY, Oh YM, Lee SD, Lee YS (2012) Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke-induced damage. Am J Physiol Lung Cell Mol Physiol 302:L891–L908. doi:10.1152/ajplung.00288.2011
Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430–436. doi:10.1038/86498
Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, Goldschmidt-Clermont PJ, Dong C, Taylor DA, Peterson ED (2006) Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 152:190–195. doi:10.1016/j.ahj.2006.02.001
Kushner EJ, Weil BR, MacEneaney OJ, Morgan RG, Mestek ML, Van Guilder GP, Diehl KJ, Stauffer BL, DeSouza CA (2010) Human aging and CD31+ T-cell number, migration, apoptotic susceptibility, and telomere length. J Appl Physiol (1985) 109:1756–1761. doi:10.1152/japplphysiol.00601.2010
Leon LJ, Gustafsson AB (2015) Staying young at heart: autophagy and adaptation to cardiac aging. J Mol Cell Cardiol. doi:10.1016/j.yjmcc.2015.11.006
Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317–325. doi:10.1038/nature10146
Moresi R, Tesei S, Costarelli L, Viticchi C, Stecconi R, Bernardini G, Provinciali M (2005) Age- and gender-related alterations of the number and clonogenic capacity of circulating CD34+ progenitor cells. Biogerontology 6:185–192. doi:10.1007/s10522-005-7954-5
Mu L, Wang J, Guo X, Zheng S, Shan K, Jing C, Li L (2014) Correlation and clinical significance of expressions of HIF-1alpha and Sema4D in colorectal carcinoma tissues. Zhonghua Wei Chang Wai Ke Za Zhi 17:388–392
Nauta ST, Deckers JW, van der Boon RM, Akkerhuis KM, van Domburg RT (2014) Risk factors for coronary heart disease and survival after myocardial infarction. Eur J Prev Cardiol 21:576–583. doi:10.1177/2047487312460514
Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P (2003) Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 7(Suppl 3):86–88
Penn MS (2009) Importance of the SDF-1:CXCR4 axis in myocardial repair. Circ Res 104:1133–1135. doi:10.1161/CIRCRESAHA.109.198929
Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy Research N (2012) Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307:1717–1726. doi:10.1001/jama.2012.418
Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:457–463. doi:10.1161/01.CIR.0000082924.75945.48
Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Grosse-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, Bohm M, Fliser D, Heine GH (2012) CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 60:1512–1520. doi:10.1016/j.jacc.2012.07.019
Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, Kaplan NM, O’Connor CM, O’Gara PT, Oparil S, American Heart Association Council for High Blood Pressure R, American Heart Association Council on Clinical C, American Heart Association Council on E, Prevention (2007) Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115:2761–2788. doi:10.1161/CIRCULATIONAHA.107.183885
Ross MD, Malone E, Florida-James G (2016) Vascular ageing and exercise: focus on cellular reparative processes. Oxid Med Cell Longev 2016:15. doi:10.1155/2016/3583956
Sanganalmath SK, Bolli R (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113:810–834. doi:10.1161/CIRCRESAHA.113.300219
Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, Wu JC, Sayre SL, Orozco A, Zierold C, Simari RD, Moye L, Cogle CR, Taylor DA, Cardiovascular Cell Therapy Research N (2015) Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circ Res 116:99–107. doi:10.1161/CIRCRESAHA.116.304710
Serrano CV Jr, Yoshida VM, Venturinelli ML, D’Amico E, Monteiro HP, Ramires JA, da Luz PL (2001) Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia. Atherosclerosis 157:505–512. doi:10.1016/S0021-9150(00)00757-7
Soucy KG, Ryoo S, Benjo A, Lim HK, Gupta G, Sohi JS, Elser J, Aon MA, Nyhan D, Shoukas AA, Berkowitz DE (2006) Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol (1985) 101:1751–1759. doi:10.1152/japplphysiol.00138.2006
Spier SA, Delp MD, Meininger CJ, Donato AJ, Ramsey MW, Muller-Delp JM (2004) Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles. J Physiol 556:947–958. doi:10.1113/jphysiol.2003.060301
Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5:213–226
Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38:274–279
Tajiri N, Duncan K, Borlongan MC, Pabon M, Acosta S, de la Pena I, Hernadez-Ontiveros D, Lozano D, Aguirre D, Reyes S, Sanberg PR, Eve DJ, Borlongan CV, Kaneko Y (2014) Adult stem cell transplantation: is gender a factor in stemness? Int J Mol Sci 15:15225–15243. doi:10.3390/ijms150915225
Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104:1209–1216. doi:10.1161/CIRCRESAHA.109.197723
Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Moye L, Ebert RF, Bolli R, Simari RD, Cogle CR (2015) Identification of bone marrow cell subpopulations associated with improved functional outcomes in patients with chronic left ventricular dysfunction: an embedded cohort evaluation of the FOCUS-CCTRN TRIAL. Cell Transplant. doi:10.3727/096368915X689901
Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247–II256
Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy R (2011) Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 306:2110–2119. doi:10.1001/jama.2011.1670
Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy Research N (2012) Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 308:2380–2389. doi:10.1001/jama.2012.28726
Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye LA, Simari RD, Cardiovascular Cell Therapy Research N (2009) Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J 158:356–363. doi:10.1016/j.ahj.2009.06.009
Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Simpson LM, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Baraniuk S, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye LA, Simari RD, Cardiovascular Cell Therapy Research N (2010) LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J 37:412–420
Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI (1995) Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 91:1861–1871
Wang H, Hou L, Kwak D, Fassett J, Xu X, Chen A, Chen W, Blazar BR, Xu Y, Hall JL, Ge JB, Bache RJ, Chen Y (2016) Increasing regulatory T cells with interleukin-2 and interleukin-2 antibody complexes attenuates lung inflammation and heart failure progression. Hypertension 68:114–122. doi:10.1161/HYPERTENSIONAHA.116.07084
Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17:1410–1422. doi:10.1038/nm.2538
Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141–148. doi:10.1016/S0140-6736(04)16626-9
Cardiovascular diseases (CVDs). Fact sheet no. 317. http://www.who.int/mediacentre/factsheets/fs317/en. Accessed 14 Aug 2014
Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW (2008) Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 39:69–74. doi:10.1161/STROKEAHA.107.489401
Zenovich AG, Panoskaltsis-Mortari A, Caron GJ, Kolb AG, Fremming R, Nelson WD, Taylor DA (2008) Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type cytokines. Transplant Proc 40:641–643. doi:10.1016/j.transproceed.2008.01.040
Zierold C, Carlson MA, Obodo UC, Wise E, Piazza VA, Meeks MW, Vojvodic RW, Baraniuk S, Henry TD, Gee AP, Ellis SG, Moye LA, Pepine CJ, Cogle CR, Taylor DA (2011) Developing mechanistic insights into cardiovascular cell therapy: cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale. Am Heart J 162:973–980. doi:10.1016/j.ahj.2011.05.024
Acknowledgements
We would like to acknowledge the National Heart, Lung, and Blood Institute, and National Center for Research Resources. The CCTRN acknowledges its industry partners, Biosafe, Biologics Delivery System Group, and Cordis Corporation, for their contributions of equipment and technical support during the conduct of the trial. Finally, we would like to thank Heather Leibrecht for her assistance in the preparation of this manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
There are no potential conflicts of interest to disclose.
Sources of funding
This work was supported by the National Heart, Lung, and Blood Institute under cooperative agreement 5 UM1 HL087318. It was also supported, in part, by National Heart, Lung, and Blood Institute contracts N01 HB 37164 and HHSN268201000008C, which were awarded to the Molecular and Cellular Therapeutics Facility, University of Minnesota, and by contracts N01 HB 37163 and HHSN268201000007C, which were awarded to the Cell Processing Facility, Baylor College of Medicine. Further funding provided by National Center for Research Resources CTSA Grant UL1 TR000064 awarded to the University of Florida. In addition, funding from the Texas State Legislature was used to assist investigators at the Texas Heart Institute, Houston, Texas.
Additional information
A. Contreras and A. Orozco contributed equally to this work.
Rights and permissions
About this article
Cite this article
Contreras, A., Orozco, A.F., Resende, M. et al. Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Res Cardiol 112, 3 (2017). https://doi.org/10.1007/s00395-016-0592-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00395-016-0592-z